Pfizer's drug for advanced lung cancer shows promising long-term trial results
The company's medicine helped patients live longer without seeing their cancer progress, as most of them experienced that benefit for over five years.
The company's medicine helped patients live longer without seeing their cancer progress, as most of them experienced that benefit for over five years.
